Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
SYSTEMATIC REVIEW/META-ANALYSIS
Patients at high risk of postoperative complications in Crohn’s disease: a meta-analysis and systematic review
1
Department of General Surgery, Chojnice Specialist Hospital, Chojnice, Poland
2
Department of General and Colorectal Surgery, Medical University of Lodz, Military Medical Academy Memorial Teaching Hospital – Central Veterans’ Hospital, Lodz, Poland
Submission date: 2025-09-01
Final revision date: 2026-01-02
Acceptance date: 2026-02-11
Online publication date: 2026-05-04
Corresponding author
KEYWORDS
treatment outcomeinflammatory bowel diseaseabdominal surgerypostsurgical complicationspredisposing factors
TOPICS
ABSTRACT
Introduction:
The aim of the study was to identify patient-related factors influencing the risk of early postoperative complications in Crohn’s disease (CD).
Material and methods:
A meta-analysis was conducted based on articles addressing early complications after abdominal surgery for CD. The analysis included the following risk factors: age, sex, hypoalbuminemia, serum C-reactive protein (CRP) levels, anemia, blood leukocyte levels, body mass index (BMI), smoking, diabetes mellitus, and hypertension. A systematic review was performed between 21 November 2021 and 4 December 2021 and repeated after three and a half years. Outcomes were reported as two effect sizes: odds ratio (OR) and response ratio (R), both with 95% CI, p-value < 0.05, and visualization in a forest plot. The strength of evidence was determined based on Egger’s test p-value, sample size, and I² statistic.
Results:
The following significant risk factors of early postoperative complications in CD were identified with Level I strength of evidence: hypoalbuminemia (OR = 1.82; 95% CI: 1.62–2.06), anemia (OR = 1.77; 95% CI: 1.47–2.15), age ≥ 40 years (OR = 1.44; 95% CI: 1.18–1.77), diabetes (OR = 1.28; 95% CI: 1.04–1.57), hypertension (OR = 1.27; 95% CI: 1.06–1.51), and smoking (OR = 1.23; 95% CI: 1.14–1.33). At Level II, the identified factors included CRP levels (R = 1.58; 95% CI: 1.32–1.89), male sex (OR = 1.23; 95% CI: 1.11–1.37), and blood leukocyte levels (R = 1.11; 95% CI: 1.07–1.15).
Conclusions:
These findings suggest that nutritional status, age, comorbidities, and parameters of blood morphology and biochemistry should be carefully considered when assessing the risk of postoperative complications in patients with CD.
The aim of the study was to identify patient-related factors influencing the risk of early postoperative complications in Crohn’s disease (CD).
Material and methods:
A meta-analysis was conducted based on articles addressing early complications after abdominal surgery for CD. The analysis included the following risk factors: age, sex, hypoalbuminemia, serum C-reactive protein (CRP) levels, anemia, blood leukocyte levels, body mass index (BMI), smoking, diabetes mellitus, and hypertension. A systematic review was performed between 21 November 2021 and 4 December 2021 and repeated after three and a half years. Outcomes were reported as two effect sizes: odds ratio (OR) and response ratio (R), both with 95% CI, p-value < 0.05, and visualization in a forest plot. The strength of evidence was determined based on Egger’s test p-value, sample size, and I² statistic.
Results:
The following significant risk factors of early postoperative complications in CD were identified with Level I strength of evidence: hypoalbuminemia (OR = 1.82; 95% CI: 1.62–2.06), anemia (OR = 1.77; 95% CI: 1.47–2.15), age ≥ 40 years (OR = 1.44; 95% CI: 1.18–1.77), diabetes (OR = 1.28; 95% CI: 1.04–1.57), hypertension (OR = 1.27; 95% CI: 1.06–1.51), and smoking (OR = 1.23; 95% CI: 1.14–1.33). At Level II, the identified factors included CRP levels (R = 1.58; 95% CI: 1.32–1.89), male sex (OR = 1.23; 95% CI: 1.11–1.37), and blood leukocyte levels (R = 1.11; 95% CI: 1.07–1.15).
Conclusions:
These findings suggest that nutritional status, age, comorbidities, and parameters of blood morphology and biochemistry should be carefully considered when assessing the risk of postoperative complications in patients with CD.
REFERENCES (78)
1.
Aniwan S, Park SH, Loftus EV. Epidemiology, natural history, and risk stratification of Crohn’s disease. Gastroenterol Clin North Am 2017; 46: 463-80.
2.
Gajendran M, Loganathan P, Catinella AP, Hashash JG. A comprehensive review and update on Crohn’s disease. Disease-a-Month 2018; 64: 20-57.
3.
Sairenji T, Collins KL, Evans DV. An update on inflammatory bowel disease. Prim Care 2017; 44: 673-92.
4.
Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn’s disease. Lancet 2017; 389: 1741-55.
5.
Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: management of Crohn’s disease in adults. Am J Gastroenterol 2018; 113: 481-517.
6.
Cushing K, Higgins PDR. Management of Crohn disease: a review. JAMA 2021; 325: 69-80.
7.
Sachar DB. Recurrence rates in Crohn’s disease: predicting the future and predicting the past. Gut 2006; 55: 1069-70.
8.
Luther A, Gabriel J, Watson RP, Francis NK. The impact of total body prehabilitation on post-operative outcomes after major abdominal surgery: a systematic review. World J Surg 2018; 42: 2781-91.
9.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71.
10.
Cohen ME, Bilimoria KY, Ko CY, Hall BL. Development of an American College of Surgeons National Surgery Quality Improvement Program: morbidity and mortality risk calculator for colorectal surgery. J Am Coll Surg 2009; 208: 1009-16.
11.
Mei Z, Wang Q, Zhang Y, et al. Risk factors for recurrence after anal fistula surgery: a meta-analysis. Int J Surg 2019; 69: 153-64.
12.
Wang FT, Lin Y, Yuan XQ, et al. Predicting short-term major postoperative complications in intestinal resection for Crohn’s disease: a machine learning-based study. World J Gastrointest Surg 2024; 16: 717-30.
13.
Lahes S, Fischer C, Spiliotis AE, et al. Effect of immunosuppressive medication on postoperative complications following abdominal surgery in Crohn’s disease patients. Int J Colorect Dis 2022; 37: 2535-42.
14.
Lavorini E, Allaix ME, Ammirati CA, Astegiano M, Morino M, Resegotti A. Late is too late? Surgical timing and postoperative complications after primary ileocolic resection for Crohn’s disease. Int J Colorect Dis 2022; 37: 843-8.
15.
Larson DW, Abd El Aziz MA, Perry W, et al. Surgical resection for crohn’s and cancer: a comparison of disease-specific risk factors and outcomes. Dig Surg 2021; 38: 120-7.
16.
Tiberi A, Pesi B, Giudici F, et al. Laparoscopic ileo-colic resection and right hemicolectomy for Crohn’s disease and colon cancer: a preliminary comparative study on post-operative outcome. Updates Surg 2020; 72: 821-6.
17.
O’Brien SJ, Chen RC, Stephen VT, et al. Preoperative opioid prescription is associated with major complications in patients with Crohn’s disease undergoing elective ileocolic resection. Dis Colon Rectum 2020; 63: 1090-101.
18.
Kline BP, Weaver T, Brinton DL, et al. Clinical and genetic factors associated with complications after Crohn’s ileocolectomy. Dis Colon Rectum 2020; 63: 357-64.
19.
Gklavas A, Poulaki A, Dellaportas D, Papaconstantinou I. Risk factors for postoperative complications after elective ileocolic resection for Crohn’s disease: a retrospective study. Ann Gastroenterol 2020; 33: 645-55.
20.
Dong X, Tang S, Liu W, et al. Prognostic significance of the Controlling Nutritional Status (CONUT) score in predicting postoperative complications in patients with Crohn’s disease. Sci Rep 2020; 10: 19040.
21.
Duan Y, Liu Y, Li Y. Previous intestinal resection is associated with postoperative complications in crohn’s disease: a cohort study. Gastroenterol Res Pract 2020; 2020: 2194382.
22.
Sakurai Kimura CM, Scanavini Neto A, Queiroz NSF, et al. Abdominal surgery in Crohn’s disease: risk factors for complications. Inflamm Intest Dis 2021; 6: 18-24.
23.
Yoon YS, Stocchi L, Holubar S, et al. When should we add a diverting loop ileostomy to laparoscopic ileocolic resection for primary Crohn’s disease? Surg Endosc 2021; 35: 2543-57.
24.
Yu CS, Jung SW, Lee JL, et al. The influence of preoperative medications on postoperative complications in patients after intestinal surgery for Crohn’s disease. Inflamm Bowel Dis 2019; 25: 1559-68.
25.
Gutiérrez A, Rivero M, Martín-Arranz MD, et al. Perioperative management and early complications after intestinal resection with ileocolonic anastomosis in Crohn’s disease: analysis from the PRACTICROHN study. Gastroenterol Rep 2019; 7: 168-75.
26.
Nguyen GC, Du L, Chong RY, Jackson TD. Hypoalbuminaemia and postoperative outcomes in inflammatory bowel disease: the NSQIP surgical cohort. J Crohn’s Colitis 2019; 13: 1433-8.
27.
Müller C, Stift A, Argeny S, et al. Delta albumin is a better prognostic marker for complications following laparoscopic intestinal resection for Crohn’s disease than albumin alone – a retrospective cohort study. PLoS One 2018; 13: E0206911.
28.
Aaltonen G, Ristimäki A, Keränen I, Carpelan-Holmström M, Lepistö A. Does a histologically inflamed resection margin increase postoperative complications in patients with Crohn’s disease? Scand J Gastroenterol 2018; 53: 279-83.
29.
Aydinli HH, Aytac E, Remzi FH, Bernstein M, Grucela AL. Factors associated with short-term morbidity in patients undergoing colon resection for Crohn’s disease. J Gastrointest Surg 2018; 22: 1434-41.
30.
Jouvin I, Lefevre JH, Creavin B, et al. Postoperative morbidity risks following ileocolic resection for crohn’s disease treated with anti-tnf alpha therapy: a retrospective study of 360 patients. Inflamm Bowel Dis 2018; 24: 422-32.
31.
Mege D, Michelassi F. Readmission after abdominal surgery for Crohn’s disease: identification of high-risk patients. J Gastrointest Surg 2018; 22: 1585-92.
32.
Atasoy D, Aghayeva A, Bilgin IA, et al. Predictive parameters of early postoperative complications in Crohn’s disease: single team experience. Turk J Gastroenterol 2018; 29: 406-10.
33.
Zhao C, Ding C, Xie T, et al. Validation and optimization of the systemic inflammation-based modified Glasgow Prognostic Score in predicting postoperative outcome of inflammatory bowel disease: preliminary data. Sci Rep 2018; 8: 747.
34.
El-Hussuna A, Pinkney T, Zmora O, et al. Risk factors for unfavourable postoperative outcome in patients with Crohn’s disease undergoing right hemicolectomy or ileocaecal resection. An international audit by ESCP and S-ECCO. Color Dis 2018; 20: 219-27.
35.
Kotze PG, Saab MP, Saab B, et al. Tumor necrosis factor alpha inhibitors did not influence postoperative morbidity after elective surgical resections in Crohn’s disease. Dig Dis Sci 2017; 62: 456-64.
36.
Lee JS, Kim HJ, Cho HM, Lee KM, Kye BH. The importance of the Crohn’s disease activity index in surgery for small bowel Crohn’s disease. J Visc Surg 2016; 153: 339-45.
37.
Li Y, Stocchi L, Cherla D, Liu X, Remzi FH. Association of preoperative narcotic use with postoperative complications and prolonged length of hospital stay in patients with Crohn disease. JAMA Surg 2016; 151: 726-34.
38.
Zhou W, Cao Q, Qi W, et al. Prognostic nutritional index predicts short-term postoperative outcomes after bowel resection for Crohn’s disease. Nutr Clin Pract 2017; 32: 92-7.
39.
Yamamoto T, Spinelli A, Suzuki Y, et al. Risk factors for complications after ileocolonic resection for Crohn’s disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: a retrospective international multicentre study. United Eur Gastroenterol J 2016; 4: 78493.
40.
Ding Z, Wu XR, Remer EM, et al. Association between high visceral fat area and postoperative complications in patients with Crohn’s disease following primary surgery. Color Dis 2016; 18: 163-72.
41.
Kulaylat AN, Hollenbeak CS, Sangster W, Stewart DB. Impact of smoking on the surgical outcome of Crohn’s disease: a propensity-score matched National Surgical Quality Improvement Program analysis. Color Dis 2015; 17: 891-902.
42.
Mege D, Bege T, Beyer-Berjot L, et al. Does faecal diversion prevent morbidity after ileocecal resection for Crohn’s disease? Retrospective series of 80 cases. ANZ J Surg 2017; 87: E74-9.
43.
Scarpa M, Martinato M, Bertin E, et al. Intestinal surgery for Crohn’s disease: role of preoperative therapy in postoperative outcome. Dig Surg 2015; 32: 243-50.
44.
Connelly TM, Juza RM, Sangster W, Sehgal R, Tappouni RF, Messaris E. Volumetric fat ratio and not body mass index is predictive of ileocolectomy outcomes in Crohn’s disease patients. Dig Surg 2014; 31: 219-24.
45.
Joyce MR, Hannaway CD, Strong SA, Fazio VW, Kiran RP. Impact of smoking on disease phenotype and postoperative outcomes for Crohn’s disease patients undergoing surgery. Langenbeck’s Arch Surg 2013; 398: 39-45.
46.
Bafford AC, Powers S, Ha C, et al. Immunosuppressive therapy does not increase operative morbidity in patients with Crohn’s disease. J Clin Gastroenterol 2013; 47: 491-5.
47.
Riss S, Bittermann C, Schwameis K, et al. Determinants for postoperative complications after laparoscopic intestinal resection for Crohn’s disease. Surg Endosc 2012; 26: 933-8.
48.
Yang SS, Yu CS, Yoon YS, Yoon SN, Lim SB, Kim JC. Risk factors for complications after bowel surgery in Korean patients with Crohn’s disease. J Korean Surg Soc 2012; 83: 141-8.
49.
Brouquet A, Blanc B, Bretagnol F, Valleur P, Bouhnik Y, Panis Y. Surgery for intestinal Crohn’s disease recurrence. Surgery 2010; 148: 936-46.
50.
Holubar SD, Dozois EJ, Privitera A, Pemberton JH, Cima RR, Larson DW. Minimally invasive colectomy for Crohns colitis: a single institution experience. Inflamm Bowel Dis 2010; 16: 1940-6.
51.
Bergamaschi R, Haughn C, Reed JF, Arnaud JP. Laparoscopic intracorporeal ileocolic resection for Crohn’s disease: is it safe? Dis Colon Rectum 2009; 52: 651-6.
52.
Sampietro GM, Corsi F, MacOni G, et al. Prospective study of long-term results and prognostic factors after conservative surgery for small bowel Crohn’s disease. Clin Gastroenterol Hepatol 2009; 7: 183-91.
53.
Takahashi-Monroy T. Surgical treatment of Crohn’s disease. Gac Med Mex 2005; 141: 351-5.
54.
Post S, Betzler M, Von Ditfurth B, Schürmann G, Küppers P, Herfarth C. Risks of intestinal anastomoses in Crohn’s disease. Ann Surg 1991; 213: 37-42.
55.
Heimann TM, Greenstein AJ, Mechanic L, Aufses AH. Early complications following surgical treatment for Crohn’s disease. Ann Surg 1985; 201: 494-8.
56.
Lindor KD, Fleming CR, Ilstrup DM. Preoperative nutritional status and other factors that influence surgical outcome in patients with Crohn’s disease. Mayo Clin Proc 1985; 60: 393-6.
57.
Ma L, Ding L, Xing Z, et al. Causal relationship between inflammatory bowel disease and cardiovascular disease: a two-sample Mendelian randomized study. Arch Med Sci 2025; 19: 577-85.
58.
Skrzypczak-Zielinska M, Gabryel M, Marszalek D, Dobrowolska A, Slomski R. NGS study of glucocorticoid response genes in inflammatory bowel disease patients. Arch Med Sci 2019; 17: 417-33.
59.
Truong A, Hanna MH, Moghadamyeghaneh Z, Stamos MJ. Implications of preoperative hypoalbuminemia in colorectal surgery. World J Gastrointest Surg 2016; 8: 353-62.
60.
Kim S, McClave SA, Martindale RG, Miller KR, Hurt RT. Hypoalbuminemia and clinical outcomes: what is the mechanism behind the relationship? Am Surg 2017; 83: 1220-7.
61.
Ge X, Liu H, Tang S, et al. Preoperative hypoalbuminemia is an independent risk factor for postoperative complications in Crohn’s disease patients with normal BMI: a cohort study. Int J Surg 2020; 79: 294-9.
62.
Ladd MR, Garcia AV, Leeds IL, et al. Malnutrition increases the risk of 30-day complications after surgery in pediatric patients with Crohn disease. J Pediatr Surg 2018; 53: 2336-45.
63.
Saad Hossne R, Sassaki LY, Baima JP, de Meira JÚnior JD, Campos LM. Analysis of risk factors and postoperative complications in patients with crohn’s disease. Arq Gastroenterol 2018; 55: 252-7.
64.
Ghoneima AS, Flashman K, Dawe V, Baldwin E, Celentano V. High risk of septic complications following surgery for Crohn’s disease in patients with preoperative anaemia, hypoalbuminemia and high CRP. Int J Colorectal Dis 2019; 34: 2185-8.
65.
Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: pathogenesis and clinical significance. JPEN J Parenter Enteral Nutr 2019; 43: 181-93.
66.
Richards SJG, Frizelle FA, Geddes JA, Eglinton TW, Hampton MB. Frailty in surgical patients. Int J Colorectal Dis 2018; 33: 1657-66.
67.
Lin HS, Watts JN, Peel NM, Hubbard RE. Frailty and post-operative outcomes in older surgical patients: a systematic review. BMC Geriatr 2016; 16: 157.
68.
Nixdorf M, Schwandner F, Klar E, Crohn M. Risikofaktoren für einen frühen OP-Zeitpunkt und chirurgische Komplikationen bei Morbus Crohn Risk Factors for Early Surgery and Surgical Complications in Crohn‘s Disease Einleitung Ergebnisse Material und Methoden.
69.
Guizzetti L, Zou G, Khanna R, et al. Development of clinical prediction models for surgery and complications in Crohn’s disease. J Crohn’s Colitis 2018; 12: 167-77.
70.
Gures N, Uludag SS, Erginoz E, Yildirim S, Erzin YZ, Zengin K. Factors affecting the development of complications in Crohn’s disease in patients undergoing intestinal resection. Medicina 2023; 102: e32957.
71.
Reese GE, Nanidis T, Borysiewicz C, Yamamoto T, Orchard T, Tekkis PP. The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies. Int J Colorectal Dis 2008; 23: 1213-21.
72.
Underner M, Perriot J, Cosnes J, Beau P, Peiffer G, Meurice JC. Tabagisme, sevrage tabagique et maladie de Crohn. Press Medicale 2016; 45: 390-402.
73.
Li D, Wu N. Mechanism and application of exosomes in the wound healing process in diabetes mellitus. Diabetes Res Clin Pract 2022; 187: 109882.
74.
Uwagbale E, Adeniran OG, Adeniran OA, Onukogu I, Agbroko S, Sonpal N. In-hospital outcomes of inflammatory bowel diseases in patients with diabetes mellitus: a propensity score matching analysis. Cureus 2021; 13: e16566.
75.
Lapage KG, Wouters PF. The patient with hypertension undergoing surgery. Curr Opin Anaesthesiol 2016; 29: 397-402.
76.
Jarmakiewicz-Czaja S, Piątek D, Filip R. The impact of selected food additives on the gastrointestinal tract in the example of nonspecific inflammatory bowel diseases. Arch Med Sci 2021; 18: 1286-96.
77.
Sánchez-Guillén L, Frasson M, García-Granero Á, et al. Risk factors for leak, complications and mortality after ileocolic anastomosis: comparison of two anastomotic techniques. Ann R Coll Surg Engl 2019; 101: 571-8.
78.
Galata C, Weiss C, Hardt J, et al. Risk factors for early postoperative complications and length of hospital stay in ileocecal resection and right hemicolectomy for Crohn’s disease: a single-center experience. Int J Colorectal Dis 2018; 33: 937-45.
Share
RELATED ARTICLE
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
